- Exchange: Xetra
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Epigenomics AG (ECX)
| Open: | 1.840 | Day's Range: | 1.801 - 1.923 | Volume: | 5,027 |
|---|---|---|---|---|---|
| Previous Close: | 1.870 | 52wk Range: | 0.716 - 2.716 | 1-Yr Rtn: | +12.59% |
Key Statistics for ECX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (EUR) (ttm) | -1.1786 |
| Est. EPS (EUR) (12/2013) | -0.8830 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 22.38 |
| Shares Outstanding (M) | 11.97 |
| 30 Day Average Volume | 17,921 |
| Price/Book (mrq) | 4.3220 |
| Price/Sale (ttm) | 16.1305 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ECX
Company Profile & Key Executives for ECX
Epigenomics AG is a molecular diagnostics company developing and commercializing a pipeline of proprietary products for cancer. The Company's products enable doctors to diagnose cancer earlier and more accurately, leading to improved outcomes for patients.
| Thomas TaapkenCFO/Member-Mgmt Board/Acting CEO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ECX News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page